A detailed history of Wellington Management Group LLP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 45,261 shares of CORT stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,261
Previous 47,790 5.29%
Holding current value
$1.99 Million
Previous $1.2 Million 22.19%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$22.21 - $34.48 $56,169 - $87,199
-2,529 Reduced 5.29%
45,261 $1.47 Million
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $1.01 Million - $1.31 Million
47,790 New
47,790 $1.2 Million
Q4 2023

Feb 12, 2024

BUY
$24.82 - $32.88 $1 Million - $1.33 Million
40,385 New
40,385 $1.31 Million
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $572,684 - $860,031
28,706 Added 345.48%
37,015 $751,000
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $205,232 - $241,958
8,309 New
8,309 $213,000
Q4 2021

Feb 11, 2022

SELL
$17.1 - $23.34 $442,872 - $604,482
-25,899 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $509,692 - $583,504
25,899 New
25,899 $510,000
Q3 2020

Nov 16, 2020

SELL
$12.46 - $19.98 $375,918 - $602,796
-30,170 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$11.0 - $18.26 $792,429 - $1.32 Million
-72,039 Reduced 70.48%
30,170 $507,000
Q1 2020

May 14, 2020

SELL
$10.11 - $14.04 $984,906 - $1.37 Million
-97,419 Reduced 48.8%
102,209 $1.22 Million
Q4 2019

Feb 11, 2020

BUY
$12.06 - $16.96 $2.41 Million - $3.39 Million
199,628 New
199,628 $2.42 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.